Recommends GH stimulation testing for patients with suspected growth hormone deficiency (GHD). Triggers include evaluating a patient for suspected GHD when single GH measurements are not helpful.
Installs into .claude/skills of the current project.
Are you the author of Ata Gh Stim Test Indication?
Add the live security badge to your README. It updates with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-ata-gh-stim-test-indication)
---
name: ata-gh-stim-test-indication
description: Recommends GH stimulation testing for patients with suspected growth hormone deficiency (GHD). Triggers include evaluating a patient for suspected GHD when single GH measurements are not helpful.
---
# Indicate GH stimulation testing for suspected growth hormone deficiency
## STEP 1 — Gather Information
Collect clinical history (symptoms of GHD, pituitary disease, prior hormone deficiencies), baseline IGF-1, BMI, and assess for contraindications; if suspicion of GHD remains, proceed to stimulation testing.
## STEP 2 — Rule In / Rule Out
Determine if clinical suspicion of GHD is present (e.g., symptoms + pituitary history + low IGF-1); if yes, rule in for GH stimulation testing; if no, rule out and consider alternative diagnoses.
## STEP 3 — Classify or Stratify
Perform a GH stimulation test (insulin tolerance, glucagon, or GHRH‑arginine) and classify peak GH response using BMI‑specific cutoffs (<3 µg/L for BMI <25, <2 µg/L for BMI 25‑30, <1 µg/L for BMI >30) to define deficiency or sufficiency.
## STEP 4 — Decide
If peak GH is below the BMI‑adjusted cutoff, diagnose GHD and consider initiating GH replacement therapy; if peak GH is above the cutoff, consider alternative diagnoses and avoid GH replacement.
## Clinical Guardrails / Mimics / Pitfalls
Do not rely on random or single GH measurements; ensure fasting and testing before 10 AM; treat known central hypothyroidism before testing to avoid false‑normal GH response; avoid testing during acute/subacute illness; adjust cutoffs for obesity; discontinue estrogen if it interferes with GH assay.
## Concrete Clinical Example
A 50‑year‑old man with prior pituitary apoplexy, decreased libido, and low IGF‑1 undergoes an insulin tolerance test; peak GH is 1.8 µg/L (BMI 28, cutoff <2 µg/L), diagnostic of GHD; GH replacement initiated at 0.3 mg/day.
**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118